Collegium Pharmaceutical (COLL) Leases (2019 - 2025)
Collegium Pharmaceutical (COLL) has 7 years of Leases data on record, last reported at $4.4 million in Q3 2025.
- For Q3 2025, Leases fell 28.16% year-over-year to $4.4 million; the TTM value through Sep 2025 reached $4.4 million, down 28.16%, while the annual FY2024 figure was $5.8 million, 3.43% down from the prior year.
- Leases reached $4.4 million in Q3 2025 per COLL's latest filing, down from $5.3 million in the prior quarter.
- Across five years, Leases topped out at $8.2 million in Q1 2021 and bottomed at $4.4 million in Q3 2025.
- Average Leases over 5 years is $6.6 million, with a median of $6.5 million recorded in 2023.
- Peak YoY movement for Leases: dropped 1.19% in 2024, then dropped 28.16% in 2025.
- A 5-year view of Leases shows it stood at $7.6 million in 2021, then dropped by 10.24% to $6.9 million in 2022, then decreased by 12.13% to $6.0 million in 2023, then decreased by 3.43% to $5.8 million in 2024, then dropped by 23.87% to $4.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.4 million in Q3 2025, $5.3 million in Q2 2025, and $5.5 million in Q1 2025.